Irbesartan/Hydrochlorothiazide 150 Mg/12.5 Mg Tablets
![](/data/mhra/doc/4b6940138b3184761433702949969533_files/4b6940138b3184761433702949969533-1.jpg)
PACKAGE LEAFLET: INFORMATION FOR THE USER
Irbesartan/Hydrochlorothiazide 150 mg/12.5 mg film-coated tablets
Irbesartan/Hydrochlorothiazide
Read all of this leaflet carefully before you start taking this medicine
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Irbesartan/Hydrochlorothiazide Tablets are and what they are used for
2. What you need to know before youtake Irbesartan/Hydrochlorothiazide Tablets
3. How to take Irbesartan/Hydrochlorothiazide Tablets
4. Possible side effects
5. How to store Irbesartan/Hydrochlorothiazide Tablets
6. Further information
1. WHAT IRBESARTAN/HYDROCHLOROTHIAZIDE TABLETS IS AND WHAT IT IS USED FOR
Irbesartan/Hydrochlorothiazide Tablets is a combination of two active substances, irbesartan and hydrochlorothiazide.
Irbesartan belongs to a group of medicines known as angiotensin-II receptor antagonists.
Angiotensin-II is a substance produced in the body that binds to receptors in blood vessels causing them to tighten. This results in an increase in blood pressure. Irbesartan prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood pressure to lower. Hydrochlorothiazide is one of a group of medicines (called thiazide diuretics) that causes increased urine output and so causes a lowering of blood pressure.
The two active ingredients in Irbesartan/Hydrochlorothiazide Tablets work together to lower blood pressure further than if either was given alone.
Irbesartan/Hydrochlorothiazide Tablets is used to treat high blood pressure, when treatment with irbesartan or hydrochlorothiazide alone did not provide adequate control of your blood pressure.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE IRBESARTAN/HYDROCHLOROTHIAZIDE TABLETS
Do not take Irbesartan/Hydrochlorothiazide Tablets
• if you are allergic (hypersensitive) to irbesartan or any of the other ingredients of Irbesartan/Hydrochlorothiazide Tablets
• if you are allergic (hypersensitive) to hydrochlorothiazide or any other sulfonamide-derived medicines
• if you are more than 3 months pregnant. (It is also better to avoid Irbesartan/Hydrochlorothiazide Tablets in early pregnancy - see pregnancy section)
• if you have severe liver or kidney problems
• if you have difficulty in producing urine
• if your doctor determines that you have persistently high calcium or low potassium levels in your blood
• if you have diabetes or impaired kidney function and you are treated with a blood lowering medicine containing aliskiren
Warnings and precautions
Talk to your doctor before taking Irbesartan/hydrochlorothiazide Tablets and if any of the following apply to you:
• if you get excessive vomiting or diarrhoea
• if you suffer from kidney problems or have a kidney transplant
• if you suffer from heart problems
• if you suffer from liver problems
• if you suffer from diabetes
• if you suffer from lupus erythematosus (also known as lupus or SLE)
• if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure).
• if you are taking any of the following medicines used to treat high blood pressure:
- an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems.
- aliskiren.
Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.
See also information under the heading “Do not take Irbesartan/ Hydrochlorothiazide Tablets”.
You must tell your doctor if you think you are (or might become) pregnant. Irbesartan/Hydrochlorothiazide Tablets is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
You should also tell your doctor:
• if you are on a low-salt diet
• if you have signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide (contained in Irbesartan/Hydrochlorothiazide Tablets)
• if you experience an increased sensitivity of the skin to the sun with symptoms of sunburn (such as redness, itching, swelling, blistering) occurring more quickly than normal
• if you are going to have an operation (surgery) or be given anaesthetics
• if you have changes in your vision or pain in one or both of your eyes
while taking Irbesartan/Hydrochlorothiazide Tablets. This could be sign that you are developing glaucoma, increased pressure in your eye(s). You should discontinue irbesartan/hydrochlorothiazide treatment and seek medical attention.
The hydrochlorothiazide contained in this medicine could produce a positive result in an anti-doping test.
Children and adolescents
Irbesartan/Hydrochlorothiazide Tablets should not be given to children and adolescents (under 18 years).
Other medicines and Irbesartan/Hydrochlorothiazide Tablets
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Diuretic agents such as the hydrochlorothiazide contained in Irbesartan/ Hydrochlorothiazide Tablets may have an effect on other medicines. Preparations containing lithium should not be taken with Irbesartan/ Hydrochlorothiazide Tablets without close supervision by your doctor.
Your doctor may need to change your dose and/or to take other precautions:
If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Irbesartan/Hydrochlorothiazide Tablets” and “Warnings and precautions”).
You may need to have blood checks if you take:
• potassium supplements
• salt substitutes containing potassium
• potassium sparing medicines or other diuretics (water tablets)
• some laxatives
• medicines for the treatment of gout
• therapeutic vitamin D supplements
• medicines to control heart rhythm
• medicines for diabetes (oral agents or insulins)
• carbamazepine (a medicine for treatment for epilepsy).
It is also important to tell your doctor if you are taking other medicines to reduce your blood pressure, steroids, medicines to treat cancer, pain killers, arthritis medicines, or colestyramine and colestipol resins for lowering blood cholesterol.
Irbesartan/Hydrochlorothiazide Tablets with food and drink
Irbesartan/Hydrochlorothiazide Tablets can be taken with or without food.
Due to the hydrochlorothiazide contained in Irbesartan/Hydrochlorothiazide Tablets, if you drink alcohol while on treatment with this medicine, you may have an increased feeling of dizziness on standing up, specially when getting up from a sitting position.
Pregnancy, breast-feeding and fertility
Pregnancy
You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking Irbesartan/ Hydrochlorothiazide Tablets before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Irbesartan/Hydrochlorothiazide Tablets. Irbesartan/Hydrochlorothiazide Tablets is not recommended during pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Breast-feeding
Tell your doctor if you are breast-feeding or about to start breast-feeding. Irbesartan/Hydrochlorothiazide Tablets is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely
Driving and using machines
No studies on the effects on the ability to drive and use machines have been performed. Irbesartan/Hydrochlorothiazide Tablets is unlikely to affect your ability to drive or use machines. However, occasionally dizziness or weariness may occur during treatment of high blood pressure. If you experience these, talk to your doctor before attempting to drive or use machines.
Irbesartan/Hydrochlorothiazide Tablets contains lactose. If you have been told by your doctor that you have an intolerance to some sugars (e.g. lactose), contact your doctor before taking this medicine.
3. HOW TO TAKE IRBESARTAN/HYDROCHLOROTHIAZIDE TABLETS
Always take Irbesartan/Hydrochlorothiazide Tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
![](/data/mhra/doc/4b6940138b3184761433702949969533_files/4b6940138b3184761433702949969533-2.jpg)
Dosage
The usual dose of Irbesartan/Hydrochlorothiazide Tablets is one or two tablets a day. Irbesartan/Hydrochlorothiazide Tablets will usually be prescribed by your doctor when your previous treatment did not reduce your blood pressure enough. Your doctor will instruct you how to switch from the previous treatment to Irbesartan/Hydrochlorothiazide Tablets.
Method of administration
Irbesartan/Hydrochlorothiazide Tablets is for oral use. Swallow the tablets with a sufficient amount of fluid (e.g. one glass of water). You can take Irbesartan/Hydrochlorothiazide Tablets with or without food. Try to take your daily dose at about the same time each day. It is important that you continue to take Irbesartan/Hydrochlorothiazide Tablets until your doctor tells you otherwise.
The maximal blood pressure lowering effect should be reached 6-8 weeks after beginning treatment.
If you take more Irbesartan/Hydrochlorothiazide Tablets than you should
If you accidentally take too many tablets, contact your doctor immediately.
Children should not take Irbesartan/Hydrochlorothiazide Tablets
Irbesartan/Hydrochlorothiazide Tablets should not be given to children under 18 years of age. If a child swallows some tablets, contact your doctor immediately.
If you forget to take Irbesartan/Hydrochlorothiazide Tablets
If you accidentally miss a daily dose, just take the next dose as normal. Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Irbesartan/Hydrochlorothiazide Tablets can cause side effects, although not everybody gets them.
Some side effects could be very serious. If you have any of the side effects below, see a doctor straight away:
• Inflammation of the pancreas characterised by severe upper stomach pain, often with nausea and vomiting.
• Toxic epidermal necrolysis characterised by allergic skin reactions like rash, hives, swelling of the face, lips, mouth, tongue or throat, headache, cough, pain in muscles or peeling of the skin all over the body.
• Necrotizing angitis (vasculitis, cutaneous vasculitis) characterised by pain in joints and muscles, skin redness, inflammation ofblood vessels.
Side effects reported in clinical studies for patients treated with Irbesartan/Hydrochlorothiazide Tablets were:
Common side effects (may affect up to 1 in 10 people)
• nausea/vomiting
• abnormal urination
• fatigue
• dizziness (including when getting up from a lying or sitting position)
• blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase) or raised levels of substances that measure kidney function (blood urea nitrogen, creatinine).
Uncommon side effects (may affect up to 1 in 100people)
• diarrhoea
• low blood pressure
• fainting
• heart rate increased
• flushing
• swelling
• sexual dysfunction (problems with sexual performance)
• blood tests may show lowered levels of potassium and sodium in your blood.
Rare (may affect up to 1 in 1,000people)
• allergic skin reactions (rash, urticaria)
• localised swelling of the face, lips and/or tongue
• short of breath
If you have any of the side effects above, see a doctor straight away.
Side effects reported since the launch of Irbesartan/ Hydrochlorothiazide Tablets
Some undesirable effects have been reported since the marketing of irbesartan and hydrochlorothiazide. Undesirable effects where the frequency is not known are: headache, ringing in the ears, cough, taste disturbance, indigestion, pain in joints and muscles, liver function abnormal and impaired kidney function, increased level of potassium in your blood and allergic reactions such as rash, hives, swelling of the face, lips, mouth, tongue or throat. Uncommon cases of jaundice (yellowing of the skin and/or white of the eyes) have also been reported.
As for any combination of two active substances, side effects associated with each individual component cannot be excluded.
Side effects associated with irbesartan alone
In addition to the side effects listed above, chest pain has also been reported.
Side effects associated with hydrochlorothiazide alone
Loss of appetite; stomach irritation; stomach cramps; constipation; jaundice (yellowing of the skin and/or whites of the eyes); sleep disorders; depression; blurred vision; lack of white blood cells, which can result in frequent infections, fever; decrease in the number of platelets (a blood cell essential for the clotting of the blood), decreased number of red blood cells (anaemia) characterised by tiredness, headaches, being short of breath when exercising, dizziness and looking pale; kidney disease; lung problems including pneumonia or build-up of fluid in the lungs; increased sensitivity of the skin to the sun; inflammation of blood vessels; a skin disease characterized by the peeling of the skin all over the body; cutaneous lupus erythematosus, which is identified by a rash that may appear on the face, neck, and scalp; allergic reactions; weakness and muscle spasm; altered heart rate; reduced blood pressure after a change in body position; swelling of the salivary glands; high sugar levels in the blood; sugar in the urine; increases in some kinds of blood fat; high uric acid levels in the blood, which may cause gout.
It is known that side effects associated with hydrochlorothiazide may increase with higher doses of hydrochlorothiazide.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE IRBESARTAN/HYDROCHLOROTHIAZIDE TABLETS
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the blister after EXP. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
What Irbesartan/Hydrochlorothiazide Tablets contains
The active substances are irbesartan and hydrochlorothiazide. Each film-coated tablet contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
The other ingredients are
Core: Carboxymethylcellulose Calcium (ECG-505), Colloidal silicon dioxide (Aerosil 200), Povidone (PVP K29/32), Sodium Starch Glycolate Type A (Glycolys), Talc & Magnesium Stearate.
Coating: Hypromellose 15 cp (E464), Lactose monohydrate, Titanium Dioxide (E171) & Polyethylene glycol 3000, Iron oxide red (E172) & Iron oxide yellow (E172)
What do Irbesartan/Hydrochlorothiazide Tablets look like ?
Irbesartan/Hydrochlorothiazide 150 mg/12.5 mg tablets are peach coloured, oval, film coated tablets debossed with “ML 34” on one side and plain on other side.
What is in a pack of Irbesartan/Hydrochlorothiazide Tablets?
Irbesartan/Hydrochlorothiazide 150 mg/12.5 mg tablets are supplied in blister packs of 28 tablets, 56 tablets and 98 tablets.
Not all pack sizes may be marketed.
lilACLEOD*
llllllllllllllllllllllllllll
Marketing Authorisation Holder
Macleods Pharma UK Limited,
Wynyard Park House, Wynyard Avenue,
Wynyard, Billingham,TS225TB,
United Kingdom
Manufacturer
Mawdsleys Brooks and Co Ltd.
Unit 22, Quest Park, Wheatley Hall Road,
Doncaster, DN2 4LT, United Kingdom.
PL 34771/0088
This medicinal product is authorised in the Member States under the following names:
United Kingdom: Irbesartan/Hydrochlorothiazide 150 mg/12.5 mg tablets Germany: Irbesartan/Hydrochlorothiazid Heumann 150 mg/12,5
mg filmtabletten
Italy: Irbesartan e Idroclorotiazide Macleods Pharma 150 mg/
12,5 mg compresse rivestite con film
Spain: Irbesartan/Hidroclorotiazida Viso Farmaceutica 150
mg/12,5 mg comprimidos recubiertos con pehcula
This leaflet was last revised in {06/2015}
T,
GO
GO